Loading…
H.R. 7391119th CongressIn committeeLatest action Feb 5, 2026Decoded by AI · checked against the record
Official title: Community Health Center Drug Pricing Protection Act
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
This bill requires drug companies to charge community health clinics the discounted 340B price upfront, not after a rebate process.
45-second read · 4 questions answered below
This bill requires that federally qualified health centers pay the discounted 340B drug price at the time of purchase. Drug manufacturers would no longer be allowed to charge full price at the register and refund the difference later. The rule applies to new drug purchases starting on the day the law takes effect and also applies to existing agreements with manufacturers.
Federally qualified health centers, which are community health clinics that serve low-income and underserved patients, are directly affected. The patients who rely on these clinics are also affected, since the clinics depend on immediate savings to fund their services.
Without upfront discounts, clinics must spend money they may not have and wait to get it back, which can strain their budgets. That strain can affect how well clinics are able to serve their communities.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Referred to the House Committee on Energy and Commerce.